In Depth 27 Jan 2021
Single-Cell Sequencing: Paving the Way for Precision Medicine
Next-generation sequencing techniques to determine an individual’s unique genetic code gave rise to personalized treatments. Single-cell sequencing is the next…
Timothé Cynober
About
Former regulatory scientist at Voisin Consulting Life Sciences in Paris. Currently working in business development at Institut Curie in big data, genomic and bioinformatic tech transfer and industrial partnerships. He describes himself as an innovative tech and therapies addict, interested in innovative health and digital tech, traveling, sports, video games and RPGs, and drawing.
Articles by Timothé Cynober
In Depth 21 Sep 2020
Why Are There Only 11 Cell and Gene Therapies in Europe?
There is a lot of talk about how cell and gene therapy are going to change medicine, so why have…
In Depth 27 Jul 2020
Biosensors: Monitoring Our Health Anywhere, Anytime
Biosensors are rapidly becoming part of our everyday life. As technology advances, we may soon be able to monitor many…
In Depth 1 Jun 2020
How Personal Genomics Companies Are Changing Drug Development
In recent years, companies offering direct-to-consumer genomics tests have started switching the business model and venturing into drug development. Amidst…
ADVERTISEMENT
In Depth 17 Jun 2019
Artificial Intelligence in Oncology: Fantasy or Reality?
Artificial intelligence promises to use the power of data to solve some of the biggest problems of our time. But…
In Depth 11 Feb 2019
CRISPR: One Patent to Rule Them All
The gene editing tool CRISPR-Cas9 has revolutionized research in biology. With several parties fighting for the rights to the technology’s…
In Depth 14 May 2018
Could Stem Cells Replace Animal Testing in Drug Development?
Animal testing is a crucial part of developing new medicines, but it comes with ethical concerns. Stem cells could eventually…
News and Trends 20 Dec 2017
How to Deal with Regulations to Get Approval for CAR-T Cells
The biotech industry is diving into the field of highly individualized gene and cell therapy products. The first CAR-T therapy has…
In Depth 20 Jul 2017
SHIVA Trial: France’s Big Shot at Precision Medicine for Cancer
SHIVA01 and SHIVA02 are large-scale trials run in France to evaluate the efficacy of precision medicine that have created ripples…
In Depth 12 Jul 2017
Genomic Testing in Oncology: From Single Genes to Whole Genomes
Personalized medicine would be nothing without genomic testing tools. Here's an overview of how the field has rapidly evolved in the…
ADVERTISEMENT
News and Trends 14 Jun 2017
Results are in for Europe’s First Biobanking Study on HPV Cervical Cancer
The RAIDs consortium made its closing event last week. After 4.5 years of studies, it has managed to change our…
News and Trends 18 Jan 2017
It’s Not Just Regulations: 9 Other Reasons Advanced Therapies Fail
For advanced therapy medicinal products (ATMPs), the regulatory process is a major challenge to reach the market; but it’s only…
In Depth 8 Sep 2016
Stem Cell Tourism makes Big Promises but may End your Life…
Desperate patients are ready to do everything to access to new treatments and Google searches can help them find medicines…